About PTB-containing, cubilin and LRP1-interacting protein
PTB-containing, cubilin and LRP1-interacting protein (PID1) is a protein
from Homo sapiens identified by UniProt accession
Q7Z2X4, 250 residues long.
MolForge cross-references it against 0 known binders and
85 disease associations.
Target properties
| Protein name | PTB-containing, cubilin and LRP1-interacting protein |
|---|
| UniProt accession | Q7Z2X4 |
|---|
| Gene | PID1 |
|---|
| Organism | Homo sapiens |
|---|
| Length | 250 residues |
|---|
| Molecular weight | — |
|---|
| EC numbers | — |
|---|
| Target class | UNCLASSIFIED |
|---|
| Subcellular location | — |
|---|
| Keywords | — |
|---|
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
|---|
| Druggability score | — |
|---|
| Pocket score | — |
|---|
| Max clinical phase | — |
|---|
Disease associations (85)
Diseases linked to this target (Open Targets).
- coronary artery disease · score 0.38
- blood phosphate measurement · score 0.38
- Antimigraine preparation use measurement · score 0.37
- cortical surface area measurement · score 0.37
- high density lipoprotein cholesterol measurement · score 0.37
- blood protein measurement · score 0.34
- angina pectoris · score 0.30
- myocardial infarction · score 0.30
- BMI-adjusted hip circumference · score 0.30
- coffee consumption · score 0.30
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
|---|
| AF-Q7Z2X4-F1 | alphafold | PREDICTED | 67.29 | — |
Amino-acid sequence (250 residues)
MFSLPLSLPL CEDTAFLPSK CCSSHKTIKQ ARTLIMIFLA SGTHFQTMLK SKLNVLTLKK EPLPAVIFHE PEAIELCTTT PLMKTRTHSG CKVTYLGKVS TTGMQFLSGC TEKPVIELWK KHTLAREDVF PANALLEIRP FQVWLHHLDH KGEATVHMDT FQVARIAYCT ADHNVSPNIF AWVYREINDD LSYQMDCHAV ECESKLEAKK LAHAMMEAFR KTFHSMKSDG RIHSNSSSEE VSQELESDDG
Explore PTB-containing, cubilin and LRP1-interacting protein with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets